Retirement, here I come 🏝️ I am pleased to announce that after a 40 year career in science I have decided it's time to make a lifestyle change and hand back my company laptop. Its been a fun ride with ONT over the past 6 years, helping to establish this exciting tech in ANZ.

The one and only Matt Loose will be keynoting a long reads for cancer seminar in Sydney on March 17, also featuring Marjan Naeini hugh Prof David Ziegler Luiza Steffens Reinhardt, Franki Tse and yours truly Register 👉🏻events.humanitix.com/long-read-sequ…

I was really looking forward to this event. Thanks for supporting Martin.

Short-read sequencing typically misses transcript isoforms that are important in health & disease. Discover how #nanopore sequencing can sequence full-length transcripts providing new detail on isoform diversity — down to #singlecell resolution: bit.ly/42iERI6

Long-read SV! Long-read sequencing of 945 Han individuals identifies structural variants associated with phenotypic diversity and disease susceptibility. #nanopore #SV doi.org/10.1038/s41467…

Retirement celebrations on the weekend. Bought the Grange when I first started working in a biotech company 40 years ago so seemed fitting to enjoy with family. Yes, it tasted fantastic 😁

Join us next week in Sydney 🇦🇺 for the first iteration of a new Ramaciotti Centre for Genomics #genomics seminar series. This session will showcase @nanoporetech through the research of two local scientists. Come for the 🧬🧑‍🔬, stay for the 🍱🍗🥒 and 🍺🍷! shorturl.at/iE2a1

Make sure to register for🧬GSA’s 2025 conference🧬! Conference @ Waipapa Taumata Rau - The University of Auckland in Aotearoa - New Zealand 🥝 from 7-10 July 2025. 🚩 Abstracts are due in three weeks (7th April) Early bird registration ends 11th May gsa-2025.com

New research just shattered the one-size-fits-all autism narrative. Turns out, autism splits into two major biological subtypes: Hypoconnectivity: Linked to synaptic dysfunction Hyperconnectivity: Tied to immune system and transcriptional dysfunction

A new approach led by Professor Lachlan Coin, PhD Candidate Daniel Rawlinson and a team of researchers identifies key features for predicting disease using complex biological data - enabling low-cost point-of-care tests for cancers and infectious diseases. 🧬

Congrats Hasindu Gamaarachchi and Nanopore Garvan team. This is an exciting development. I remember asking myself how AS might be used when it was first released. You have truely answered this 🙌🎉

Part 1 and 2 of the Long-read sequencing Special Issues are now live! tinyurl.com/Genome-Res-LRS

Woo hoo 😎

Fantastic to see you moving this progressively forward and demonstrate the immediate impact it can have on lives. You're a legend Rhys and ESR 💪

Join Sebastian Lunke at his first #nanoporeconf where he will share their discoveries utilising targeted sequencing (adaptive sampling) on the #PromethION for disease research – providing a fast and cost-effective approach to confirm clinical variants. nanoporetech.com/about/events/c…

In this breakout, discover how the latest analysis tools are enabling rapid, high quality T2T genomes at a lower cost than current methods. Also learn how to uncover TR characterisation, methylation and more – enabling rich insights into human disease. nanoporetech.com/about/events/c…

New postdoc opening UNSW in RNA biology and T cell immunity 🥼🧬🧫. Use molecular biology, nanopore sequencing, and in vivo models to uncover the regulatory drivers of adaptive immunity. Apply 👉 tinyurl.com/422n7hr6

London Calling 2025: What I'm Thinking About 🧬🖥️ omicsomics.blogspot.com/2025/05/london…

Really excited about this work. Critically needed for critically endangered species. #Nanoporeconf

I am very happy to share our latest PD genetics work. It is a two‐sample Mendelian randomization (MR) study that uses gene regulatory networks from different tissues to raise questions about Parkinson’s disease (PD) genetics. Should we rethink some assumptions about PD?